Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB)
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
This study is an evaluation of the short term effects on CNV perfusion of a same-day
administration of photodynamic therapy (PDT) with Visudyne® and an intravitreal injection of
Lucentis® (ranibizumab, 0.3 mg). An evaluation of the short term effects on CNV perfusion of
this combined treatment is needed for better understanding of treatment effects.